I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Popejoy, Myra
30
results:
Search for persons
X
Format
Online (30)
Mediatypes
Articles (Online) (21)
OpenAccess-fulltext (9)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and Safety of Adintrevimab (ADG20) for the Treatme..:
Ison, Michael G
;
Popejoy, Myra
;
Evgeniev, Nikolay
...
Open Forum Infectious Diseases. , 2023
Link:
https://doi.org/10.1093/..
?
2
591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) i..:
Rubino, Christopher M
;
Cammarata, Anthony P
;
Ambrose, Paul
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
3
1132. Integrated Quantitative Systems Pharmacology (QSP) Ch..:
Tarbell, Evan
;
Van Wart, Scott A
;
Popejoy, Myra
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
4
1113. Clinical and Virologic Outcomes with Early Adintrevim..:
Mahoney, Kathryn
;
Narayan, Kristin
;
Betancourt, Natalia
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
5
Outcomes of Ceftolozane/Tazobactam (C/T) in Patients With M..:
Palchak, Melissa
;
Popejoy, Myra
;
Miller, Benjamin
Open Forum Infectious Diseases. 2 (2015) suppl_1 - p. , 2015
Link:
https://doi.org/10.1093/..
?
6
Clinical Outcomes of Ceftolozane/Tazobactam Treatment of Pi..:
Popejoy, Myra
;
Armstrong, Eliana
;
Miller, Benjamin
...
Open Forum Infectious Diseases. 2 (2015) suppl_1 - p. , 2015
Link:
https://doi.org/10.1093/..
?
7
Ceftolozane/Tazobactam Plus Metronidazole for Complicated I..:
Solomkin, Joseph
;
Hershberger, Ellie
;
Miller, Benjamin
...
Clinical Infectious Diseases. 60 (2015) 10 - p. 1462-1471 , 2015
Link:
https://doi.org/10.1093/..
?
8
Ceftolozane/Tazobactam Plus Metronidazole for Complicated I..:
Solomkin, Joseph
;
Hershberger, Ellie
;
Miller, Benjamin
...
Clinical Infectious Diseases. 60 (2015) 10 - p. 1462-1471 , 2015
Link:
https://www.jstor.org/st..
?
9
260Ceftolozane/Tazobactam for the Treatment of cUTI and cIA..:
Popejoy, Myra
;
Cloutier, Daniel
;
Huntington, Jennifer
...
Open Forum Infectious Diseases. 1 (2014) suppl_1 - p. S111-S111 , 2014
Link:
https://doi.org/10.1093/..
?
10
Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronid..:
Jackson, Carl-Christian A.
;
Newland, Jason
;
Dementieva, Nataliia
...
Pediatric Infectious Disease Journal. 42 (2023) 7 - p. 557-563 , 2023
Link:
https://doi.org/10.1097/..
?
11
Safety and Efficacy of Ceftolozane/Tazobactam Versus Merope..:
Roilides, Emmanuel
;
Ashouri, Negar
;
Bradley, John S.
...
Pediatric Infectious Disease Journal. 42 (2023) 4 - p. 292-298 , 2023
Link:
https://doi.org/10.1097/..
?
12
1154. Safety and Efficacy of Ceftolozane/Tazobactam Plus Me..:
Jackson, Carl-Christian A
;
Newland, Jason
;
Dementieva, Natalia
...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S668-S669 , 2021
Link:
https://doi.org/10.1093/..
?
13
Reply to Chao and Lai:
Wunderink, Richard G
;
Roquilly, Antoine
;
Croce, Martin
...
Clinical Infectious Diseases. 73 (2021) 8 - p. 1552-1553 , 2021
Link:
https://doi.org/10.1093/..
?
14
A Phase 3, Randomized, Double-Blind Study Comparing Tedizol..:
Wunderink, Richard G
;
Roquilly, Antoine
;
Croce, Martin
...
Clinical Infectious Diseases. 73 (2021) 3 - p. e710-e718 , 2021
Link:
https://doi.org/10.1093/..
?
15
1143. Safety and Efficacy of Ceftolozane/Tazobactam Versus ..:
Roilides, Emmanuel
;
Ashouri, Negar
;
Bradley, John S
...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S663-S664 , 2021
Link:
https://doi.org/10.1093/..
1-15